Ovarian Stimulation in Obese and Non-obese Polycystic Ovary Syndrome Using a Low-dose Step-up Regimen with Two Different Starting Doses of Recombinant Follicle-stimulating Hormone

By Yildizhan R   Adali E   Kolusari A   Kurdoglu M   Yildizhan B   Sahin HG   Kamaci M  

The Journal of International Medical Research, Vol. 36, Iss. 6, 2008-11 ,pp. : 1197-1204

Field House Publishing

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone: a controversial issue – without controversy

By Shoham Zeev  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1033-1044

Informa Healthcare

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone: a scientific step to clinical improvement

By Hugues J-N  

Reproductive BioMedicine Online, Vol. 2, Iss. 1, 2001-01 ,pp. : 54-64

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Clinical Outcomes of Ovulation Induction with Metformin, Clomiphene Citrate and Human Menopausal Gonadotrophin in Polycystic Ovary Syndrome

By Cheng J   Lv J   Li CY   Xue Y   Huang Z   Zheng W  

The Journal of International Medical Research, Vol. 38, Iss. 4, 2010-07 ,pp. : 1250-1258

Field House Publishing

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone: gold standard or not?

By Out Henk J  

Reproductive BioMedicine Online, Vol. 11, Iss. 5, 2005-11 ,pp. : 536-539

Reproductive Healthcare Ltd

Access to resources Recommend Favorite